138 related articles for article (PubMed ID: 31867617)
1. Integron-Related Resistance in New Emerged Staphylococcus lugdunensis Infection in Burn Patients.
Pirbonyeh N; Emami A; Bazargani A; Javanmardi F; Hosseini SM; Derakhshan B
J Burn Care Res; 2020 May; 41(3):598-603. PubMed ID: 31867617
[TBL] [Abstract][Full Text] [Related]
2. Emergence of oxacillin-resistant Staphylococcus lugdunensis carrying staphylococcal cassette chromosome mec type V in central Taiwan.
Yen TY; Sung YJ; Lin HC; Peng CT; Tien N; Hwang KP; Lu JJ
J Microbiol Immunol Infect; 2016 Dec; 49(6):885-891. PubMed ID: 25648670
[TBL] [Abstract][Full Text] [Related]
3. The Occurrence of Type I, II, and III Integrons in Multi-drug Resistance and Methicillin-Resistant Staphylococcus aureus Isolates in Iran.
Mohammadi M; Bahrami N; Khajavian M; Faghri J
Curr Microbiol; 2020 Aug; 77(8):1653-1659. PubMed ID: 32279187
[TBL] [Abstract][Full Text] [Related]
4. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
[TBL] [Abstract][Full Text] [Related]
5. Frequency, clinical manifestations, and outcomes of Staphylococcus lugdunensis Bacteremia in children.
Sato M; Kubota N; Horiuchi A; Kasai M; Minami K; Matsui H
J Infect Chemother; 2016 May; 22(5):298-302. PubMed ID: 26898664
[TBL] [Abstract][Full Text] [Related]
6. The frequency of class1 and 2 integrons in Pseudomonas aeruginosa strains isolated from burn patients in a burn center of Ahvaz, Iran.
Khosravi AD; Motahar M; Abbasi Montazeri E
PLoS One; 2017; 12(8):e0183061. PubMed ID: 28813520
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance and integron carriage in clinical isolates of Pseudomonas aeruginosa in Tehran, Iran.
Moazami Goudarzi S; Eftekhar F
Turk J Med Sci; 2015; 45(4):789-93. PubMed ID: 26422847
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis.
Lourtet-Hascoët J; Bicart-See A; Félicé MP; Giordano G; Bonnet E
Int J Infect Dis; 2016 Oct; 51():56-61. PubMed ID: 27609028
[TBL] [Abstract][Full Text] [Related]
9. First record of isolation and characterization of methicillin resistant Staphylococcus lugdunensis from clinical samples in Iraq.
Al-Charrakh AH; Obayes MH
Biomed Res Int; 2014; 2014():736259. PubMed ID: 25126573
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis.
McHardy IH; Veltman J; Hindler J; Bruxvoort K; Carvalho MM; Humphries RM
J Clin Microbiol; 2017 Feb; 55(2):585-595. PubMed ID: 27927926
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of class 1 integrons and plasmid-mediated qnr-genes among Enterobacter isolates obtained from hospitalized patients in Ahvaz, Iran.
Amin M; Dibachi S; Shahin M
Infez Med; 2017 Dec; 25(4):351-357. PubMed ID: 29286015
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and antimicrobial susceptibility of Staphylococcus lugdunensis in a Greek tertiary-care hospital.
Kachrimanidou M; Malliou P; Meletis G; Netsika F; Mavrovouniotis I; Protonotariou E; Skoura L
New Microbiol; 2020 Jul; 43(3):133-135. PubMed ID: 32596739
[TBL] [Abstract][Full Text] [Related]
13. Clinical and microbiological properties of Staphylococcus lugdunensis skin infections.
Zaaroura H; Geffen Y; Bergman R; Avitan-Hersh E
J Dermatol; 2018 Aug; 45(8):994-999. PubMed ID: 29897142
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of imipenem-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Burns Hospital in Tunisia: detection of a novel class 1 integron.
Chairat S; Ben Yahia H; Rojo-Bezares B; Sáenz Y; Torres C; Ben Slama K
J Chemother; 2019 May; 31(3):120-126. PubMed ID: 30849001
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States.
Farrell DJ; Mendes RE; Bensaci M
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):85-88. PubMed ID: 30314652
[TBL] [Abstract][Full Text] [Related]
16. Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran.
Faghri J; Nouri S; Jalalifar S; Zalipoor M; Halaji M
BMC Res Notes; 2018 Nov; 11(1):806. PubMed ID: 30419962
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan.
Lin JF; Cheng CW; Kuo AJ; Liu TP; Yang CC; Huang CT; Lee MH; Lu JJ
J Microbiol Immunol Infect; 2015 Aug; 48(4):406-12. PubMed ID: 24529852
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional study of Staphyloccus lugdunensis prevalence in cats.
Bierowiec K
Sci Rep; 2020 Sep; 10(1):15417. PubMed ID: 32963280
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Class 1 Integrons and Extended Spectrum Beta Lactamases among Multi-Drug Resistant Escherichia coli Isolates from North of Iran.
Mehdipour Moghaddam MJ; Mirbagheri AA; Salehi Z; Habibzade SM
Iran Biomed J; 2015; 19(4):233-9. PubMed ID: 26220727
[TBL] [Abstract][Full Text] [Related]
20. Abscesses and wound infections due to Staphylococcus lugdunensis: report of 16 cases.
Papapetropoulos N; Papapetropoulou M; Vantarakis A
Infection; 2013 Apr; 41(2):525-8. PubMed ID: 23242962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
